MUR
44
-3
AXP
67
-2
CMI
64
-3
DE
42
3
KR
36
-6
MMM
35
-5
JNJ
41
3
CTAS
53
-3
AIZ
82
2
SWK
50
-5
AA
56
15
MTB
65
-2
BXP
49
-3
CRM
60
-7
BEN
50
9
ACN
47
-5
EQT
51
-3
MS
77
-2
GT
56
-3
SRE
63
2
MUR
44
-3
AXP
67
-2
CMI
64
-3
DE
42
3
KR
36
-6
MMM
35
-5
JNJ
41
3
CTAS
53
-3
AIZ
82
2
SWK
50
-5
AA
56
15
MTB
65
-2
BXP
49
-3
CRM
60
-7
BEN
50
9
ACN
47
-5
EQT
51
-3
MS
77
-2
GT
56
-3
SRE
63
2
Financhill
Back

Ultra Clean Holdings Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
26

UCTT
Ultra Clean Holdings

Last Price:
33.96
Seasonality Move:
19.11%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
26
Ultra Clean Holdings (UCTT) is a Sell

Is Ultra Clean Holdings a Buy, Sell or Hold?

  • The current Ultra Clean Holdings [UCTT] share price is $33.97. The Score for UCTT is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • UCTT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

UCTT Stock Price Chart

What is Ultra Clean Holdings's stock price today?

  • The Ultra Clean Holdings share price today is $33.97
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and UCTT is experiencing slight selling pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

UCTT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.44 Sell
Relative Strength Index (14 RSI): 41.28 Sell
Chaikin Money Flow: -87678 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.37 - 37.95) Sell
Bollinger Bands (100): (33.54 - 46.12) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

UCTT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.34 Sell
20-day SMA: 35.59 Sell
50-day SMA: 36.29 Sell
200-day SMA: 42.05 Sell
8-day EMA: 35.47 Sell
20-day EMA: 35.96 Sell
50-day EMA: 36.9 Sell
200-day EMA: 39.1 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Ultra Clean Holdings Earnings Growth & UCTT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.42 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.89 per share, and an increase next year of $1.38 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Ultra Clean Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):